{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:35:04Z","timestamp":1785825304294,"version":"3.56.0"},"reference-count":51,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1080\/14787210.2024.2401560","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T05:03:08Z","timestamp":1725685388000},"page":"753-759","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Alternative drugs for the treatment of gonococcal infections: old and new"],"prefix":"10.1080","volume":"22","author":[{"given":"Susannah","family":"Franco","sequence":"first","affiliation":[{"name":"Department of Pharmacy, State University of New York Downstate Health Sciences University, Brooklyn, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret R.","family":"Hammerschlag","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases, State University of New York Downstate Health Sciences University, Brooklyn, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"e_1_3_4_3_1","unstructured":"Centers for Disease Control and Prevention. sexually transmitted disease surveillance. 2022 [cited 2024 May 13]. Available from: https:\/\/www.cdc.gov\/std\/statistics\/2022\/default.htm"},{"key":"e_1_3_4_4_1","unstructured":"World Health Organization. Gonorrhoea (Neisseria gonorrhoeae infection). [cited 2024 May 13]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/gonorrhoea-(neisseria-gonorrhoeae-infection)"},{"key":"e_1_3_4_5_1","unstructured":"Centers for Disease Control and Prevention. Addressing the threat of drug-resistant gonorrhea [cited 2024 May 13]. Available from: https:\/\/www.cdc.gov\/nchhstp\/newsroom\/docs\/factsheets\/drug-resistant-gonorrhea.pdf"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir694"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6950a6"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.10.015"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac682"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-024-01023-3"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7004a1"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30116-1"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000971"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa559"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa108"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01739-20"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00625-3"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00326-12"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics6040024"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04536-14"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2015.05.007"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.4c00128"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy145"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706988"},{"key":"e_1_3_4_25_1","unstructured":"GSK announces positive headline results from EAGLE-1 phase III trial for gepotidacin in uncomplicated urogenital gonorrhoea (GC). [cited 2024 May 13]. Available from: https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/gsk-announces-positive-headline-results-from-eagle-1-phase-iii-trial-for-gepotidacin-in-uncomplicated-urogenital-gonorrhoea-gc\/"},{"key":"e_1_3_4_26_1","unstructured":"Positive results announced in largest pivotal phase 3 trial of a first-in-class oral antibiotic to treat uncomplicated gonorrhoea. [cited 2024 May 13]. Available from: https:\/\/gardp.org\/positive-results-announced-in-largest-pivotal-phase-3-trial-of-a-first-in-class-oral-antibiotic-to-treat-uncomplicated-gonorrhoea\/"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01221-18"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00862-6"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac322"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001548"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2019.1621161"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep43047"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/1751143714564816"},{"key":"e_1_3_4_34_1","volume-title":"Sexually transmitted disease surveillance 2022: gonococcal isolate surveillance project national profile","author":"Centers for Disease Control and Prevention","year":"2024","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2022: gonococcal isolate surveillance project national profile. Atlanta: U.S. Department of Health and Human Services; 2024."},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa067"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01808-18"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01263-21"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498254.2015.1112933"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13477"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mpaic.2020.02.003"},{"key":"e_1_3_4_41_1","volume-title":"Package insert","author":"AZACTAM (aztreonam for injection, USP)","year":"2018","unstructured":"AZACTAM (aztreonam for injection, USP). Package insert. Bristol-Myers Squibb; 2018."},{"key":"e_1_3_4_42_1","volume-title":"INVANZ (ertapenem for injection). Package insert","year":"2022","unstructured":"INVANZ (ertapenem for injection). Package insert. Merck; 2022."},{"key":"e_1_3_4_43_1","unstructured":"Biga LM Bronson S Dawson S et al. 23.3 the mouth pharynx and esophagus. Anatomy physiology. 2019 Sep 26 [cited 2024 Jun 12]. Available from: https:\/\/open.oregonstate.education\/aandp\/chapter\/23-3-the-mouth-pharynx-and-esophagus\/"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1177\/01455613221081568"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-0956-8_6"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016345"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00521-20"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkae063"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab074"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.682135"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-49943-z"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00863-20"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1128\/mra.01130-22"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2024.2401560","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T05:42:14Z","timestamp":1732772534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2024.2401560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1080\/14787210.2024.2401560"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2024.2401560","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-06-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}